Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Upstream of Ikaros.

David Liberg1, Stephen T Smale, Matthias Merkenschlager

  • 1Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK. david.liberg@csc.mrc.ac.uk

Trends in Immunology
|November 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancer.

JCI insight·2026
Same author

Neutrophil Transcriptomic Changes in Severe Sterile Vasoplegic Syndrome Resemble a Distinct Molecular Subtype of Septic Shock.

Shock (Augusta, Ga.)·2026
Same author

Correction: HPV16-Expressing Tumors Release Multiple IL1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine.

Cancer discovery·2026
Same author

Relationship among Toll-like receptors, β2 adrenergic receptor, and mitogen-activated protein kinases in regulating Il1b transcription.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Uncovering the regulatory landscape of early human B cell lymphopoiesis and its implications in the pathogenesis of B-ALL.

Science advances·2025
Same author

PBK/TOPK mediates Ikaros, Aiolos and CTCF displacement from mitotic chromosomes and alters chromatin accessibility at selected C2H2-zinc finger protein binding sites.

Nature communications·2025

Haematopoiesis, the creation of blood cells from stem cells, is regulated by the DNA-binding protein Ikaros. New research explores how Ikaros itself is controlled, offering insights into cellular differentiation.

Area of Science:

  • Hematology
  • Molecular Biology
  • Developmental Biology

Background:

  • Haematopoiesis is a fundamental biological process involving the differentiation of hematopoietic stem cells into various blood cell types.
  • Lineage-specific gene expression patterns define distinct cell types within the hematopoietic system.
  • The DNA-binding protein Ikaros is recognized as a key regulator in the process of haematopoiesis.

Purpose of the Study:

  • To elucidate the regulatory mechanisms governing the function of Ikaros in haematopoiesis.
  • To understand how Ikaros itself is regulated within the context of cellular commitment and differentiation.
  • To provide novel insights into the molecular control of blood cell development.

Main Methods:

  • Investigating the upstream regulators of Ikaros activity.

Related Experiment Videos

  • Analyzing gene expression changes associated with Ikaros function.
  • Utilizing molecular biology techniques to study protein-protein interactions involving Ikaros.

    • Main Results:

    • Identification of novel factors that modulate Ikaros activity.
    • Characterization of the downstream targets of Ikaros in hematopoietic stem cells.
    • Demonstration of how Ikaros regulation impacts lineage-specific differentiation pathways.

    Conclusions:

    • The regulation of Ikaros is crucial for proper haematopoiesis and cellular differentiation.
    • Understanding Ikaros regulation provides a deeper insight into developmental biology and hematological disorders.
    • Further research into Ikaros will illuminate fundamental mechanisms of cell fate determination.